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Bloodstream infection (BSI) is a major cause of death in developed countries and the
detection of microorganisms is essential in managing patients. Despite major progress
has been made to improve identification of microorganisms, blood culture (BC) remains
the gold standard and the first line tool for detecting BSIs. Consensus guidelines are
available to ensure optimal BSI procedures, but BC practices often deviate from the
recommendations. This review provides an update on clinical and technical issues related
to blood collection and to BC performance, with a special focus on the blood sample
strategy to optimize the sensitivity and specificity of BCs.
Keywords: bloodstream infection, blood culture, single sampling strategy, multi-sampling strategy, sensitivity,
specificity, contamination
INTRODUCTION
Bloodstream infections (BSIs) represent a growing public health concern, with an estimated burden
of 1,200,000 episodes of BSI each year in Europe, and 157,000 attributable deaths (Goto and Al
Hasan, 2013). BSI ranks among the top seven causes of death in North America and Europe.
The diagnosis of BSI relies on the documentation of pathogens in blood—either bacteremia, or
fungemia—through blood cultures (BCs). Indeed, although the last decades have experienced
dramatic achievements in the development of rapid diagnostic tests relying on innovative
technologies, BCs remain the gold-standard not only for the diagnosis of BSI, but also for the
identification of the responsible pathogen(s), and for the testing of their susceptibility to anti-
infective agents. Since the mid-1970s, various original studies, systematic reviews, and guidelines
to better define the principles and practices of BCs sampling and processing have been published.
The available evidence suggests that the diagnostic yield of BCs is influenced by the collection of
appropriate specimens, from selected patients with reasonable suspicion of BSI. We performed
a systematic literature review on clinical and technical issues related to blood collection, as well as
interpretation of BCs, in adult patients suspected of BSI. We focused on the impact of BC collection
strategies on their performance for the diagnosis of BSI, as this has not been a major focus in most
recent reviews (e.g., Kirn and Weinstein, 2013; Garcia et al., 2015).
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ORDERING BLOOD CULTURES
Published guidelines do not clearly state when BCs should be
ordered (Baron et al., 2013). Blood cultures are commonly
collected when patients have fever, chills, leukocytosis, septic
shock, suspected endocarditis or prior to starting antimicrobial
treatment in elderly or immunocompromised patients.
Physicians significantly overestimate the likelihood of BSI
for their patients (Poses and Anthony, 1991). Indeed, in most
settings, only 5 to 13% of BCs will turn out to be positive, and
of those, 20–56% represent contaminants (Bates et al., 1990;
Salluzzo and Reilly, 1991; Little et al., 1997; Dargère et al., 2014).
Despite progress in skin antisepsis since 25 years led to lower
risk of contamination (e.g., 0.5–1%, Garcia et al., 2015), rates of
contamination as high as 2.1–6% are still commonly reported,
and the 20–56% proportion of contaminants holds true today
(e.g., Zwang and Albert, 2006; Gander et al., 2009; Roth et al.,
2010; Dargère et al., 2014).
Many models for predicting bacteremia have been developed
but not all were validated and, when they were, the validation
processes were highly heterogeneous (Bates et al., 1990; Shapiro
et al., 2008; Coburn et al., 2012). Eliakim-Raz et al. (2015)
identified studies that underwent validation on prediction of
bacteremia and that were able to define groups with low (<3%)
or high (>30%) probabilities of bacteremia in adults. They
demonstrated that few studies have been prospectively validated,
populations and parameters included were heterogeneous and
none of these models were implemented in clinical practice
(Eliakim-Raz et al., 2015). The additional workload required
to enter data may explain the reluctance to use these models.
Multicenter clinical trials would be necessary to better define the
added value of models to guide BC ordering strategies in clinical
practice.
TIMING OF BC SPECIMEN COLLECTION
Thus far, the most appropriate timing of BC collection has
been poorly evaluated through clinical studies. Most guidelines
state that blood specimens should be collected in the absence
of antimicrobials, at or around the time of fever spikes, and
a 30–60 min interval between samples has been arbitrarily
recommended (Weinstein, 1996). However, in a seven-center
study that evaluated the timing of BC collection in relation
to body temperature in 1436 patients with BSI, Riedel et al.
(2008) could not identify any optimal timing for BC collection.
Indeed, the likelihood of documenting BSIs was not significantly
enhanced by collecting blood during temperature spikes. Yields
were similar over a 24-h period before and after temperature
spikes (Riedel et al., 2008). Consistent with these results, Li et al.
(1994) found no difference in BCs yield whether samples were
collected within a 24-h period, either simultaneously or serially
(Li et al., 1994).
BLOOD CULTURE COLLECTION
Skin Preparation
Meticulous skin antisepsis at the time of blood collection is
paramount to reduce the risk of BC contamination, so that
the rate of contaminants would remain below the threshold of
3% of all BCs sampled (Garcia et al., 2015). In a systematic
review, Malani et al. (2007) found that: (i) alcoholic iodine
tincture is more effective than aqueous povidone-iodine (PVI) to
reduce the risk of BC contamination; (ii) alcoholic chlorhexidine
gluconate (CHG) is more effective than aqueous PVI; (iii)
alcoholic antiseptics are more effective than aqueous products,
and (iv) that alcohol alone is not inferior to any iodine products
(Malani et al., 2007). In a more recent meta-analysis of 6 clinical
trials, alcoholic chlorhexidine was found to bemore effective than
non-alcoholic PVI, while alcoholic solutions were more effective
than non-alcoholic solutions. This review found no significant
difference between chlorhexidine and iodine products for skin
antisepsis before blood collection (Caldeira et al., 2011). The
Clinical and Laboratory Standards Institute (CLSI) guidelines for
BCs collection favor the use of CHG for infants>2months of age,
children and adults (Wilson et al., 2007); and the Food and Drug
administration recommended to use it with care in premature
infants or infants under 2 months of age. These products may
cause irritation or chemical burns (Schiffenbauer, 2012).
A recent randomized crossover trial comparing the
effectiveness of 3 skin antiseptic interventions—10% aqueous
PVI solution, 2% iodine tincture (IT), and 2% CHG in 70%
isopropyl alcohol—before BCs sampling, found that the choice
of antiseptic agent does not impact contamination rates when
BCs are sampled by a dedicated phlebotomy team (Washer et al.,
2013). A systematic review and meta-analysis concluded that the
implementation of dedicated phlebotomy teams reduce the rate
of BCs, while no evidence support the use of prepackaged prep
kits (Snyder et al., 2012). In addition, it has been demonstrated
that BCs contamination rates are significantly lower when an
antiseptic agent is applied on BC bottle tops before sampling
(Schifman et al., 1998). European and French guidelines
recommend the use of an alcoholic solution for antisepsis before
BC sampling (Lamy and Seifert, 2012; Accoceberry et al., 2015a).
For an extensive review on skin antisepsis before BC collection
and prepackaged kits performance, see Garcia et al. (2015).
Sampling Site
Several studies concluded that peripheral venipuncture is the
method of choice for BC collection, as compared with sampling
through intravenous catheter, with rates of contamination
ranging from 1.2 to 7.3% when samples are obtained from
venipuncture compared with 3.4 to 13% when blood is drawn
through catheter (Dawson, 2014; Garcia et al., 2015). Indeed,
both colonization of the catheter, and breakdowns in sterile
procedure increase the risk of BCs contamination when BCs
samples are drawn through these devices (Bates et al., 1991). A
multi-interventional study that included education of healthcare
workers to avoid the sampling of BCs from central intravenous
lines, documented simultaneous decreases in (i) the proportion
of BCs obtained from central lines (from 10.9 to 0.4%); and
(ii) BCs contamination rates (from 1.6 to 0.5%; Boyce et al.,
2013). Although studies have shown that contamination rates
are lower for BCs drawn from newly inserted catheter using a
sterile technique protocol (Levin et al., 2013), BCs are usually
even less contaminated when samples are drawn by peripheral
venipuncture (Snyder et al., 2012).
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One exception must be outlined: for the diagnosis of
central line associated BSI (CLABSI), most current guidelines
recommend simultaneous sampling of BC drawn from the
suspected catheter, and through a venipuncture, to be able to
estimate the differential time to positive BC (Baron et al., 2013;
Dellinger et al., 2013). Indeed, if BC drawn from the central line
grows at least 2 h earlier than BC drawn from venipuncture, the
central line is most likely the source of BSI (Kirn and Weinstein,
2013). However, improper collection of BCs is associated with
potential over-reporting of CLABSI (Kaasch et al., 2014; Garcia
et al., 2015).
Despite concordant recommendations, the techniques for
collection of BCs vary across countries in routine practice.
A study performed in intensive care units across 4 European
countries found that the preferred means for BCs collection
were peripheral venipuncture in Germany and Italy (42 and
76% via peripheral venipuncture, respectively, vs. 8 and 0% via
intravenous catheter, while 50 and 24% reported no preference),
while sampling through intravenous catheter was more common
in France and the UK (respectively, 33 and 23% via intravenous
catheter, vs. 20 and 23% via peripheral venipuncture, while 47 and
54% reported no preference; Schmitz et al., 2013).
Impact of Volume Sampled on BCs Yield
Data available could be summarized as follows: “The higher the
blood volume cultured, the higher the yield.” Indeed, adequate
volume sampling is the most important parameter for the
detection of bloodstream microorganisms because bacterial or
fungal density in blood is very low in most patients with BSI.
Basically, the likelihood of detecting a BSI depends on the
bacterial or fungal concentration, and on the volume collected.
Using theoretical models, Arpi et al. (1989) estimated the average
bacterial concentration in patients with bacterial BSI at 0.25
colony-forming unit (CFU) per milliliter, and Jonsson et al.
(1993) demonstrated that the bacterial concentration was less
than 0.04 CFU/mL in 29% of Escherichia coli BSI and 18% of
Staphylococcus aureus BSI (Arpi et al., 1989; Jonsson et al., 1993).
The sensitivity of BC was estimated to be 95% when 3 CFU
are sampled, which implies that at least 30 mL of blood are
incubated (Jonsson et al., 1993). The results of this model are
in full agreement with Washington’s empirical data obtained 18
years earlier, showing that a total volume of at least 30ml of
blood is required for detecting 99% of BSI (Washington, 1975).
There are very few clinical studies directly evaluating the bacterial
concentration in BSI, because this measurement requires the
use of quantitative BC techniques, which are particularly labor-
intensive, and not routinely used. These studies are consequently
either originating from the early years of BCs, decades ago (with
potential limitation due to the quality of the culture media used),
or more recent, based on the lysis-centrifugation technique, but
limited to a specific type of BSI (Tables 1, 2). For instance, Wain
et al. (1998) showed that 53% of 349 patients with enteric fever
had a Salmonella enterica serovar Typhi concentration between
0.01 and 1 CFU/mL of blood (Wain et al., 1998). In Reynes’s
study, 54.3% of 1026 patients with BSI (any type) had a bacterial
density between 0.1 and 2 CFU/ mL of blood (Reynes, 1947).
Similar data have been observed with Candida BSI (Table 2), and
in Pfeiffer et al.’s study, 53% of 152 patients had a fungal density
of less than 1 CFU/mL (Pfeiffer et al., 2011). Overall, data from
modeling, as well as clinical studies are remarkably concordant:
50% of BSI episodes are associated with a bacterial concentration
in the range of 0.01–1 CFU/mL (Tables 1, 2).
Comparing the yield of standard-volume BC (mean, 8.7mL),
and low-volume BC (mean, 2.7mL), a study from the Wisconsin
Hospital and Clinics demonstrated that the sensitivity of BCs for
the diagnosis of BSI was 92% with standard-volume, and 69%
with low-volume (difference of 23%, [95% CI, 9–37%]; P< 0,
001; Mermel and Maki, 1993). Examining 7783 BCs, including
624 classified as true positive BCs, Li et al. (1994) demonstrated
that increasing the volume of blood cultured from 20 to 40mL
increased the yield by 19%, with an additional gain of 10% when
the incubated volume was increased from 40 to 60mL (Li et al.,
1994). Since then, several studies have confirmed that the volume
of blood cultured is the key parameter of BC yield (Cockerill
et al., 2004; Patel et al., 2011). The most recent studies showed
that sampling blood volumes of 20, 40, and 60mL was associated
with sensitivities of 65.0–75.7%, 80.4–89.2%, and 95.7–97.7%,
respectively (Cockerill et al., 2004; Bouza et al., 2007; Lee et al.,
2007; Patel et al., 2011).
Of note, since Washington’s seminal works (Washington,
1975), the recommended volume of blood to be cultured
gradually increased over decades. This increase resulted both
from the need to develop (and accept) the concept of culturing
larger volumes of blood, and from the study design on which data
relied on: in the absence of perfect gold standard for detecting
BSI, the 100% of BSI detected in each study is bounded by
the maximum volume of blood cultured, with an inherent risk
to under-detect BSI in case of lower volumes. Finally, since
the 1970’s, the changes in BSI epidemiology that have been
reported may have been in part impacted by these changes in
sampling techniques, and culture media system: as most BSI are
associated with a low bacterial or fungal density, improvement
in BCs sensitivity most likely increased the incidence of
documented BSI, and may also have impacted on their
patterns.
Current Guidelines
As they are based on similar literature data, guidelines from
scientific societies are in agreement on most issues. The
UK Standards for Microbiology Investigations recommend 4
bottles (2 sets), corresponding to 20–30 mL per set (Public
Health England, 2014). The French Society of Microbiology
recommends that, in patients suspected of BSI, 4–6 bottles (2
to 3 sets) of blood should be cultured, with adequate volume
for each bottle. A 6 bottles-procedure is necessary whenever
the optimal filling of all the bottles is not ensured (Accoceberry
et al., 2015a). The European guidelines also recommend the
culture of 4–6 bottles adequately filled (Lamy and Seifert,
2012). The American College of Critical Care Medicine (ACCM)
and Infectious Diseases Society of America (IDSA) Guidelines
recommend that new fever in critically ill adult patients must
be investigated by drawing of 3–4 BC sets with appropriate
volume within the 24 h of fever onset (O’Grady et al., 2008).
Guidelines from the American Society of Microbiology (ASM)
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TABLE 1 | Bacterial concentration in blood from adult bloodstream infections.
References Bacterial concentration Type of
bloodstream
infection
Number of
patients
0.01 0.1 1 2 5 10 50 100 >100
Warren and Herrick, 1916 ? 35%
<------------------------------>
..
..
..
..
..
..
39%
<------------------------------------------------------------------------>
..
..
..
..
..
..
16%
<----------------------------------->
..
..
..
..
..
..
10%
<------------------------------------
Any type of
bacteriemia
124
Hébert and Bloch, 1921 ? 25%
<------------------------------>
..
..
..
..
..
..
67%
<------------------------------------------------------------------------>
..
..
..
..
..
..
8%
<----------------------------------->
..
..
..
..
..
..
0%?
<-----------------------
Typhoid
fever
12
Reynes, 1947 ? 54%
<-------------------------------------------->
..
..
..
..
..
..
13%
<--------------------------->
..
..
..
..
..
..
7%
< ---------------------------->
..
..
..
..
..
..
8%
<---------------------->
..
..
..
..
..
..
17%
<------------------------------------------------
Any type of
bacteriemia
1026
Watson and Pietermaritzburg, 1955 ? 7%
<------------------------------>
..
..
..
..
..
..
67%
<----------------------------------------------------------------------->
..
..
..
..
..
..
26%
<--------------------------------->
..
..
..
..
..
..
0%?
<-------------------------
Typhoid
fever
15
Werner et al., 1967 ? 0%?
<-----------------------
24%
<----------------------------------------------------------------------->
..
..
..
..
..
..
34%
<--------------->
..
..
..
..
..
..
15%
<------------------>
..
..
..
..
..
..
17%
<--------------------------------------
Infective
endocarditis
206
Henry et al., 1983 ? 41%
<------------------------------>
..
..
..
..
..
..
16%
<----------------------------------------------------------------------->
..
..
..
..
..
..
42%
<----------------------------------------------------------------------->
Any type of
bacteriemia
61
Kiehn et al., 1983 ? 54%
<------------------------------>
..
..
..
..
..
..
28%
<----------------------------------------------------------------------->
..
..
..
..
..
..
11%
<----------------------------------->
..
..
..
..
..
..
..
..
..
..
..
..
6%
<------------------------------------
Any type of
bacteriemia
385
Wain et al., 1998 25%
<--------------->
..
..
..
..
..
..
28%
<----------------->
..
..
..
..
..
..
34%
<------------------------------------------------------------------------>
..
..
..
..
..
..
12%
<----------------------------------->
..
..
..
..
..
..
1%
<------------------------------------
Typhoid
fever
349
All studies from this table performed colony count using the pour plate or spread plate technique. As methodology varies between studies, concentration range and categories vary. Of
note, the quality and fertility of culture media may have varied between 1916 and 1998.
TABLE 2 | Fungal concentration in blood from bloodstream infection.
References Fungal concentration Type of patients Number of
patients
0.01 0.1 1 2 5 10 50 100 >100
Henry et al., 1983 36%
<------------------------------------------------->
..
..
..
..
..
..
26%
<----------------------------------------------------->
..
..
..
..
..
..
38%
<------------------------------------------------------------------------------
Adult only 61
Kiehn et al., 1983 47%
<------------------------------------------------->
..
..
..
..
..
..
30%
<----------------------------------------------------->
..
..
..
..
..
..
15%
<----------------------------------->
..
..
..
..
..
..
8%
<-----------------------------
– 91
Bille et al., 1984 52%
<-------------------------------------------------------------------------------->
..
..
..
..
..
..
48%
<------------------------------------------------------------------------------------------------------>
– 23
Kiehn, 1989 26%
<------------------------------------------------->
..
..
..
..
..
..
28%
<------------------------------------------------------->
..
..
..
..
..
..
24%
<--------------------------------------------->
..
..
..
..
..
..
22%
<--------------------------------
Immunocompro-
mised patient
68
Pfeiffer et al., 2011 19%
<------------------------------->
..
..
..
..
..
..
35%
<----------------->
..
..
..
..
..
..
21%
<------------------------------------------------------->
..
..
..
..
..
..
12%
<--------------------------------------------->
..
..
..
..
..
..
13%
<--------------------------------
Adult and children 152
have long been similar (Baron et al., 2005b). Recent ASM/IDSA
joint guidelines for adults recommend 20–30mL of blood per
culture set, which, according to these guidelines, may require
more than 2 bottles depending on the system. Generally, in adults
with a suspicion of BSI, 2–4 BC sets should be obtained in the
evaluation of each septic episode (Baron et al., 2013; Dellinger
et al., 2013).
For optimal recovery, each BC set should include paired
aerobic and anaerobic bottles, the aerobic bottle being filled first.
Besides, the culture of only 2 bottles (1 set) during a 24-h period
from adult patients (hereafter referred to as “solitary BC”), is
discouraged in all guidelines, as the sensitivity of only 2 bottles
is insufficient. In addition, it must be taken into account that,
in the real life, a significant proportion of BCs bottles are not
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adequately filled (Vitrat-Hincky et al., 2011; Willems et al., 2012;
Lin et al., 2013; van Ingen et al., 2013; Coorevits and Van den
Abeele, 2015). The “solitary BC” practice, still common, is not
acceptable, due to the detrimental outcome when BSI is not
detected and appropriately managed, in terms of antimicrobial
treatment (a positive BC will impact on the selection of active
anti-infective agents for the appropriate treatment duration), but
also to trigger the identification, and eradication of the BSI source
(Lamy and Seifert, 2012; Baron et al., 2013; Accoceberry et al.,
2015a).
Compliance with Guidelines and Current Caveats
An increasing amount of data highlights the pre-analytical
deficiencies of BC sampling which may compromise patient
management by reducing BCs diagnostic yield (Schifman et al.,
1991; Washington, 1992; Novis et al., 2001).
Firstly, BC bottles that should contain 8–10mL of blood
(manufacturer instructions) are frequently under-filled,
consequently leading to sets of much less than 20mL, or—
although less commonly—over-filled (>10mL). Mermel and
Maki (1993) first highlighted the issue of under-filled BC
bottles, a situation that was not center-specific, since 88% of
71 U.S. laboratories acknowledged that they routinely receive
BC specimens from adults containing less than 5mL of blood
(Mermel and Maki, 1993). In Spain, in a prospective analysis
conducted from 601 patients with suspected BSI, the mean
volume of blood per BC bottle was estimated at 5mL (Bouza
et al., 2007). Similar sobering results have been reported from
all over the world, with wide variations between countries
(Table 3).
On the other hand, BC bottles are inoculated with more than
10 mL of blood in 7.6–13% of cases (Table 3). These bottles are
at increased risk to be falsely flagged positive by the BC system
(Wilson et al., 1994; Reimer et al., 1997). According to Willems
et al. (2012), both Becton Dickinson R© (BD) and bioMérieux R©
admitted that the vacuum in the BC bottles substantially exceeds
the optimal blood fill volume (10mL; Willems et al., 2012). The
purpose of the vacuum excess is to ensure a sufficiently long
expiration date, and to minimize the collection time. All these
data underline how common are situations of non-compliance
with manufacturer instructions, regarding the volume of blood
to be inoculated for optimal diagnostic yield.
Secondly, BCs are commonly “solitary BC,” for various
reasons (e.g., resolution of fever, venipuncture failures, patients
discharged home, or to another department where the ordering
of BCs is discontinued, omission in collecting subsequent BC
sets). Several studies reported rates of solitary BC per center
between 10 and 33.3% (Table 4). Proportions of solitary BC
seem to be lower in the US, with medians of 26%, and 12.7%
(Schifman et al., 1991; Novis et al., 2001), which may be related
to the implementation of quality control programs that include
this indicator, and to the fact that the personnel primarily
responsible for BC collection are dedicated phlebotomists, two
major differences with practices in most European countries. The
combined effect of under-filled BC bottles and high proportion of
solitary BCs, results in a high proportion of patients suspected of
BSI for whom the total volume of blood inoculated is insufficient.
Given the critical importance of sampling the adequate
amount of blood for BC sensitivity, monitoring the volume
of blood cultured is a strong quality-assurance requirement
(Mermel and Maki, 1993; Schifman et al., 1996; Willems et al.,
2012; Chang et al., 2015; Accoceberry et al., 2015a). It should
be surveyed through systematic program, either internal or
external to the microbiology lab, and should at least include the
proportions of solitary BC, and of adequately filled BC bottles
(Schifman et al., 1991, 1996; Mermel andMaki, 1993; Novis et al.,
2001; Willems et al., 2012; van Ingen et al., 2013; Chang et al.,
2015; Accoceberry et al., 2015a). This latter may be estimated
through either measurement of the weight of BC bottles received
at the laboratories or visual inspection, although the latter is less
accurate.
Sampling Strategy
Sampling an adequate volume of blood to ensure optimal
sensitivity for BSI detection can be achieved either by increasing
the number of venipunctures (hereafter, “multi-sampling
strategy”) or by collecting the adequate large volume through
one single puncture (hereafter, “single-sampling strategy”).
Multi-Sampling Strategy
Rationale
The multi-sampling strategy has been developed, and
recommended for more than 40 years, and its practice has
been generalized (Washington, 1975, 1992). The rationale of
this strategy is based on the following points: (i) repetition of
samples increases the total volume of blood cultured, thereby
improving BC sensitivity, (ii) separate samples may discriminate
contaminants from pathogens when BCs grow, (iii) separate
samples improve BSI detection in case of intermittent bacteremia
(Washington, 1975; Reimer et al., 1997).
It has been successful to improve BSI detection in several
studies which concluded that, under routine circumstances, at
least two separate sets of BCs should be sampled during a 24-
h period for the diagnosis of BSIs (Mermel and Maki, 1993; Li
et al., 1994; Weinstein, 1996; Cockerill et al., 2004; Bouza et al.,
2007; Lee et al., 2007), and guidelines recommend two to three -
or four - BC sets (O’Grady et al., 2008; Lamy and Seifert, 2012;
Baron et al., 2013; Dellinger et al., 2013; Public Health England,
2014; Accoceberry et al., 2015a).
Interpretation of positive culture results
The differentiation between clinically significant positive BCs
(i.e., the micro-organism identified is involved in the symptoms
presented by the patient), and contaminants, is based on the
number of positive BC samples when the culture yielded
an organism regarded as a common contaminant [e.g.,
coagulase-negative staphylococci (CoNS), Corynebacterium spp,
Micrococcus spp, etc.] (MacGregor and Beaty, 1972). For these
microorganisms, at least 2 positive BCs yielding the same
CoNS are usually required to consider the results as clinically
significant, given that the likelihood that it represents true
bacteremia as opposed to contamination increases with the
number of positive bottles (Weinstein, 1996; Reimer et al., 1997;
Kirn and Weinstein, 2013; Garcia et al., 2015). This can assist
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TABLE 3 | Quality of bottle filling.
Under-filled bottles Over-filled bottles
References Threshold (mL) Rate (%) Threshold (mL) Rate (%) Country
Vitrat-Hincky et al., 2011 < 8 65 >10 13.0 France
Willems et al., 2012a,b < 8 26.2–36.0 >12 7.6-12.8 Belgium
van Ingen et al., 2013 < 8 55.3 – – The Nederlands
Coorevits and Van den Abeele, 2015 < 8 28.0 >12 23.2 Belgium
Chang et al., 2015 < 8 97.7 >10 0.2 South Korea
Lin et al., 2013 < 7 28.3 >10 13.3 Taiwan
Mermel and Maki, 1993 < 5 20 – – USA
Chang et al., 2015 < 3 48.4 – – South Korea
aData from 5 hospitals
bThresholds were defined as 2mL below and above the recommended volume per vial.
TABLE 4 | Rate of solitary blood cultures.
References No. of institutions Rate (%)
Gross et al., 1988 1 28.0
Makadon et al., 1987 1 20.0
Schifman et al., 1991 38 26.0 (median)
Schifman et al., 1996 909 10.1–12.1 (inpatients)
25.4–33.3 (outpatients)
Novis et al., 2001 333 12.7 (median)
Vitrat-Hincky et al., 2011 1 28.0
Neves et al., 2015 1 23.2
in interpreting positive BC results, although the clinical context,
including the presence of intravascular foreign devices, is also
of paramount importance for an accurate interpretation of BCs
positive for CoNS.
Limitations
Despite these recommendations, several issues have been
highlighted: firstly, the proportion of solitary BCs is high with
the multi-sampling strategy (Schifman et al., 1991; Vitrat-Hincky
et al., 2011; Neves et al., 2015), and these are associated with
a major default of sensitivity. In addition, solitary BC makes
it more difficult to distinguish contaminants from pathogens.
Secondly, each venipuncture required for the multisampling
strategy is an additional opportunity for contamination (Aronson
and Bor, 1987; Lamy et al., 2002; Patel et al., 2011). The
contamination rate per draw has been estimated at 0.5–6%
(Bates et al., 1991; Salluzzo and Reilly, 1991; Washington,
1992; Arendrup et al., 1996; Garcia et al., 2015). However,
considering that only one positive sample may be interpreted
as a confirmation that the patient has, indeed, BSI, and that the
prevalence of BSI among patients suspected of BSI is relatively
low, the proportion of false-positive among patients with positive
BC may be as high as 20–56% (Bates et al., 1991; Salluzzo
and Reilly, 1991; Little et al., 1997). The consequences of BC
contamination and false positives, although poorly studied, are
not trivial, as they may lead to longer hospital stays, useless
prescription of antibacterial or antifungal agents, additional
investigations (e.g., echocardiography, repeated sampling for BC;
Bates et al., 1991; Souvenir et al., 1998; Hall and Lyman, 2006;
Gander et al., 2009; Alahmadi et al., 2011). In a retrospective
case-control study on 254 false-positive BC results, Alahmadi
et al. (2011) demonstrated that hospital length of stay increased
by 5.4 days (2.8–8.1), with an additional hospital cost of
£1,270,381 per year. In another study, contaminated BCs
increased patient charges by 47%with an estimated cost of $8,720
per contamination (Gander et al., 2009). Souvenir et al. (1998)
reported that almost half of patients with positive BCs that were
finally classified as “contaminants” were treated with antibiotics,
including 34% by vancomycin. Additional costs were estimated at
$1000 per patient in this study, with a median increase in length
of stay of 4.5 days (Souvenir et al., 1998). False-positive BCs
generated a 20% increase in laboratory tests and a 39% increase
in intravenous antibiotic charges in another study (Bates et al.,
1991).
Finally, the theoretical concept of intermittent bacteremia or
fungemia that supports the multi-sampling strategy has never
been proved. Evidence suggests that most cases of clinically
significant BSI are associated with continuous bacteremia or
fungemia over a 24 h period, but with very low concentrations of
circulating microorganisms (Jonsson et al., 1993; Li et al., 1994;
Riedel et al., 2008).
Single-Sampling Strategy
Rationale
The single-sampling strategy collects the total volume of blood
from one single draw, a “BC set” of 4 to 6 bottles. This strategy
satisfies both the need to collect a sufficient volume of blood,
and the need to decrease contamination rate by limiting the
number of punctures. In addition, this would be associated
with decreased workload and risk of occupational exposure
to blood-transmissible pathogens for nurses, decreased cost,
and improved comfort for patients, by reducing the number
of invasive, potentially painful, procedures. This strategy was
developed since the late 1990s, based on the following: (i)
the concept of intermittent bacteremia or fungemia may be
erroneous (Jonsson et al., 1993; Li et al., 1994; Riedel et al., 2008);
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(ii) the key determinant for the capacity of BCs to diagnose BSI is
the total volume of blood inoculated (Li et al., 1994); (iii) the rate
of false-positive results increases with the number of draws; (iv)
for a given volume of blood inoculated, the multi- and single-
sampling strategies are expected to have similar sensitivity; (v)
because the total volume is obtained at once with the single-
sampling strategy, there is no risk of omitting subsequent draws,
thereby eradicating the risk of solitary BC. Hence, the median
total volume of blood inoculated will necessarily be greater;
(vi) the single-sampling strategy should enable early initiation
of empirical antibiotic treatment when indicated (e.g., severe
sepsis), as there will be no need to postpone until subsequent
sampling; and (vii) patient comfort will be improved, as only one
venipuncture will be requested for this strategy.
First, as mentioned above, Li et al. (1994) demonstrated that
increasing the volume of blood inoculated increases the yield of
BC, whether or not BCs are drawn simultaneously or serially
within 24 h (Li et al., 1994). To reconcile the interpretation of
previous data (Washington, 1975; Cockerill et al., 2004) with
these results, it has been hypothesized that the need to repeat
BC sampling originated from the poor sensitivity when small
volume of blood are inoculated (< 20mL per set). In such a
procedure, the detection depends on the bacterial density at time
of samplings, and not all samples will turn positive. Hence, when
large volume of blood is inoculated on BC media (i.e., 40 or
60mL), the sensitivity of the single-sampling strategy is high
whenever the sample is obtained and is similar to the sensitivity
of multi-sampling strategy (Figure 1; Li et al., 1994; Lamy et al.,
2002).
Arendrup et al. (1996) first evaluated the single-sampling
strategy in their institution (Arendrup et al., 1996). Inoculating
a single-sampling of 40-mL BC (4 bottles), instead of 30-mL BC
(3 bottles) increased the diagnostic yield of BC by 4.2%. Using a
before/after design, the authors concluded that this strategy had
a positive impact on workload, and early initiation of empirical
antimicrobial therapy. In most cases of positive BCs due to
contaminants, only one or two of the four bottles turned positive,
and the interpretation of positive BCs with a microorganism of
questionable significance was not more difficult than with the
multi-sampling strategy (Arendrup et al., 1996).
Two studies evaluated the impact of the number of draws
on the risk of false-positive BCs (specificity), and quantified it
using theoretical probabilistic approach (Aronson and Bor, 1987;
Lamy et al., 2002). Both confirmed the negative impact of the
number of separate sampling on BC specificity. Onemodel-based
study compared the performance (sensitivity and specificity)
of the multi-sampling vs. the single-sampling strategies, using
literature-based simulations and a quantitative risk-analysis
approach. The median specificity of positive BCs decreased from
0.98 with the single-sampling strategy, to 0.91 with the 3 sample-
strategy, which resulted, with a pretest probability of BSI set at
15%, in a median positive predictive value decrease from 0.85 to
0.66, respectively (Lamy et al., 2002). On the opposite, a 6 bottle-
collection of blood at once (totalizing 35–42mL) ensured an
efficient diagnosis of bacterial BSI with an optimized specificity
(Lamy et al., 2002). In this scenario, with a median volume
of 7mL of blood per bottle, the sensitivity was ≥0.95 in 89%
FIGURE 1 | Blood culture result (negative or positive) according to the
amount of blood cultured at each sampling and to the microbial
burden in blood. The curve represents the bacterial concentration (β) in blood
that varies with time and may be very low, but never null. The limit of
bacteremia detection (BC sensitivity) is indicated with dotted line. Each sample
is represented by a box. (A) Culturing low volumes of blood does not ensure
sensitive testing and low detection threshold, and thus leads to uncertain
bacteremia detection according to time of collection. The overall results
suggest an intermittent bacteremia. (B) Culturing large volumes of blood
ensures low detection threshold, thus allowing detecting bacteremia whenever
the sample is obtained. One sample is enough for confidently detecting
bacteremia; the overall results would suggest a continuous bacteremia.
of the trials, and the median specificity was 97.5%. Recently, a
prospective study performed in the adult emergency departments
of three university hospitals compared a single-sampling strategy
collecting one large volume of blood (4 bottles), to the standard
multi-sampling strategy. Overall, the single-sampling strategy
allowed detection of pathogens in blood of 97.4% of patients
vs. 95.5% for the multi-sampling strategy. In the subgroup of
patients for whom two sets were drawn, the single-sampling
strategy was superior to the multi-sampling strategy in term of
positive results. In addition, considering the overall performances
(sensitivity and specificity), the single-sampling strategy was
significantly better than the multi-sampling strategy (Dargère
et al., 2014). Finally, as expected, the proportion of solitary BC
rate was strikingly reduced by using the single-sampling strategy.
Although this strategy has been approved in France as an
alternative to the multi-sampling strategy since 2007 (SFM, 2007)
a nationwide survey conducted in 47 hospitals found that only
17 and 21% of them were using the single-sampling strategy
in 2013, exclusively and partly, respectively (Royer et al., 2015).
In Denmark, where the single-sampling strategy first spread,
a survey on BC practices was conducted in 2015 among 6/11
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departments of clinical microbiology, covering half of Danish
hospital admissions (1.28/2.57 millions admission). Responses
showed that 1 out of 6 departments practiced the multi-sampling
strategy, 2 practiced either multi-sampling or single-sampling
strategy, and 3 hospitals practiced the single-sampling strategy.
Five of these centers use the multi-sampling strategy when
endocarditis is suspected.
Interpretation of positive BC results
Rules for interpretation of positive BC results, and distinction
between BSI and contamination, differ with the single-sampling
strategy, as the information given by the proportion of positive
BC sets at different times cannot be used. In order to define
guideline to differentiate clinically significant bacteria from
contaminants with this strategy, a study was conducted between
2007 and 2008 in Lyon University Hospital (France), where
the single-sampling strategy has been implemented in 2004
(Leyssene et al., 2011). In monomicrobial positive sets (one set
being defined as 6 bottles originating from a single venipuncture),
the positive predictive value (PPV) of BC was 88 and 100% with,
respectively, one and ≥2 positive bottles for E. coli, while it was
100% for S. aureus, Pseudomonas aeruginosa, and Candida spp.,
whatever the number of positive bottles. For CoNS, the PPV
with one, two, three or ≥4 positive bottle(s) was 3.5, 61.1, 78.9,
and 100%, respectively. The most difficult cases to interpret were
those with 2 or 3 positive bottles out of the 6 cultured, but
this was the case for only 5% of patients with CoNS-growing
BC. Therefore, despite systematic evaluations of an approach
based on the number of positive bottles have proven to be
unreliable when using the multi-sampling strategy (Mirrett et al.,
2001b; Kirn and Weinstein, 2013), the clinical significance of
CoNS-growing BC was correlated with the number of positive
bottles when using the single-sampling strategy (Leyssene et al.,
2011). Similar findings were observed in Arendrup et al. study
(Arendrup et al., 1996). Consistent with these data, Dargère et al.
(2014) showed that most contaminants were detected only in the
first aerobic bottle of the 4-bottle set with the single-sampling
strategy, and that the most frequent microorganism was CoNS
(Dargère et al., 2014).
Limitations
Firstly, getting a sufficient volume of blood to fill 6 bottles from a
single venipuncture may be difficult, particularly in the elderly,
and in patients with shock. This may require an additional
puncture to collect the total volume of blood necessary for
optimal diagnostic yield of BCs. Secondly, the level of evidence
on the performance of the single-sampling strategy remains low:
only two published studies evaluated the performances of a
single-sampling strategy based on inoculating 40 mL of blood
(Arendrup et al., 1996; Dargère et al., 2014). The first one was
a quasi-experimental study (i.e., before/after design), and the
second one was randomized, but limited by sample size (n =
2374). Indeed, this lack of studies is mainly due to the fact
that comparative studies are difficult to perform as they require
a complex design to prevent biases, large sample sizes to be
adequately powered, and a strict methodology to control the
volume of blood actually cultured in each group. Thirdly, level
of evidence is also lacking for specific situations such as infective
endocarditis (IE)—for which the number of positive samples on
distinct venipunctures is part of the modified Duke Criteria (Li
et al., 2000)—or for CLABSI. A high BC sensitivity is expected
for detecting IE with the single-sampling strategy because of
the high density of bacteria in blood (Werner et al., 1967), but
modified Duke Criteria would require to be adapted if the single-
sampling strategy was to be generalized. In patients suspected
of CLABSI, the diagnosis may be obtained through a single-
sampling strategy (4–6 bottles) obtained through venipuncture,
associated with one appropriately filled bottle simultaneously
drawn from the catheter line to be able to estimate the differential
time to positive BC (DTTP). Indeed, despite one peripheral
BC set has been shown to be appropriate for the DTTP-based
diagnosis of CLABSI (Mermel et al., 2009; Guembe et al., 2012),
a 4–6 bottle set drawn by venipuncture is still indicated for the
diagnosis of BSI, whatever the source, including thus BSI other
than CLABSI. However, such protocols need to be investigated.
In addition, to the best of our knowledge, the medico-
economic aspects of these two strategies have not been
thoroughly evaluated. Other potential impacts of the single-
sampling strategy remain to be measured, including patient
comfort (e.g., only one venipuncture with the single-
sampling strategy), the risk of occupational-exposure to
blood-transmissible pathogens, and the timing of empirical
anti-infective agent initiation.
BLOOD CULTURE SYSTEMS
In this review, considerations on BC systems will be limited to
those that may impact the performance (sensitivity, specificity) of
BSI diagnosis. Overall, three continuous-monitoring automated
BC systems are available in 2015. The two system most
commonly used are, by far, the Bactec (Beckton-Dickinson, USA)
and BactAlert/Virtuo systems (bioMérieux, France). These two
systems are based on the utilization of carbohydrate substrates
in culture media, and subsequent production of CO2 by growing
microorganisms, detected through their impact on pH, by either
a colorimetric, or a fluorescent sensor placed at the bottom of
the bottle. Both systems have similar characteristics, and, despite
differences in culture media, they share similar performances for
detection of microorganisms (Kirn and Weinstein, 2013). The
fertility of the culture media used in these systems is among the
highest among broth media available in clinical microbiology.
Media are combined in sets in order to include aerobic and
anaerobic formulations, and those associated with resins or
charcoal regularly show better performances as compared to
standard media (Weinstein et al., 1995; Wilson et al., 1995, 2001;
Gibb et al., 1998; Mirrett et al., 2004). Only slight improvements
in the performances have been achieved over the last 15 years
(e.g., Kirn et al., 2014).
Combined with inadequate sampling volumes, the early use
of antibiotics prior to the first blood sample is a critical factor
hampering microorganism recovery. Some media include resin
or charcoal to neutralize antibiotics. The superior neutralizing
capacity of resin-based media over the bioMérieux charcoal
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medium has been demonstrated (Flayhart et al., 2007), but
discrepancies have been reported and the complete neutralization
might be insufficient. The types and compositions of resins, the
type of antibiotics and the MICs of the test strains may account
for the differences in neutralization performance (Mitteregger
et al., 2013). As far as possible, BCs should be obtained before
the antimicrobial therapy is initiated.
False-Positive Instrument Signal
False-positive instrument signal, defined as a bottle flagged
positive by the system though not containing any micro-
organism, has been described with the systems, in less than 1% of
bottles (Pohlman et al., 1995; Mirrett et al., 2001a). These false-
positive bottles require quick handle and re-incubation into the
BC system (e.g., within 1 h following their unloading) in order to
resume the bottle analysis. Major causes of false-positive results
include high level of leukocyte counts, over-filled bottles and/or
errors in incubation so that the bottles are monitored with an
inappropriate algorithm (Wilson et al., 1994; Reimer et al., 1997).
However, available data are scarce andmostly derive from studies
of media that are not in use anymore. Given the significant
changes inmedia formulation over years, updated evaluations are
required to evaluate the actual incidence of false-positive signals,
and the effect of over-filled bottles on positivity.
False-Negative Instrument Signal
False-negative instrument signal is defined as a bottle flagged
negative by the system although it contains bacteria or fungi. The
main parameter associated with false-negative signal is the pre-
incubation delay, which is the time difference between the time
point of bottle loading in the BC incubator and the time point of
bottles filling. It has been estimated that 0.3 to 15.3% of bottles
containing bacteria or fungi are flagged negative by BC system
(Reimer et al., 1997; Klaerner et al., 2000; Mirrett et al., 2001a;
Lemming et al., 2004; Seegmüller et al., 2004), although few of
the media currently in use have been evaluated for this default.
The false-negative signal depends on the temperature at which
the bottles were kept before loading (hereafter pre-incubation
temperature), the pre-incubation duration, the type of micro-
organism involved, and the pairing instrument/type of bottle
used. Overall, the false negative signal rate was greater when
pre-incubation temperature was 35◦C, pre-incubation duration
was > 24 h, with streptococci, Candida sp, or Pseudomonas sp,
and with Bactec systems (Sautter et al., 2006). A pre-incubation
duration < 12 h kept the risk of false negative at its minimum
(Lemming et al., 2004; Seegmüller et al., 2004; Akan and Yildiz,
2006; Sautter et al., 2006). It has been hypothesized that micro-
organisms grow in the bottle during the pre-incubation duration,
especially with high temperature (35◦C), so that they have already
reached the stationary phase at time of loading. In such a
situation, positive bottles cannot be detected by the instrument
algorithms. Only 60% of false-negative signals were detected by
visual inspection before loading (Lemming et al., 2004). Pre-
incubation at 35◦C should be discouraged (Lamy and Seifert,
2012; Baron et al., 2013; Kirn and Weinstein, 2013; Accoceberry
et al., 2015a), and suppliers have revised their guidelines in this
way. Indeed, bottles should be delivered to the laboratory and
loaded in the BC system as fast as possible (Seegmüller et al.,
2004). This point is pivotal especially as studies on BC transport
time have shown that delayed entry negatively impacts on time to
positivity from the time point of sampling (Ronnberg et al., 2013)
or on the positive BC rate (Morton et al., 2015). Indeed, Morton
et al. (2015) highlighted that BC yield was lower when BCs were
collected during the week-end, and this was likely caused by
delays or errors in incubation and processing, in relation with
the reduced provision of support services during the week-ends
(Morton et al., 2015).
Monitoring the Volume of Blood Inoculated
As underlined, a major cause for missing a diagnosis of BSI is
insufficient filling of BC bottles, which leads to a sub-optimal
sensitivity. Improvement of BCs bottle filling would require
enhanced training of phlebotomists, including systematic visual
inspection of bottle filling at the bedside (van Ingen et al.,
2013). In addition, some BC system manufacturers developed
automated systems to estimate the level of bottle filling at the
time of loading (Chang et al., 2015). The Bactec FX system (BD,
USA), based on red blood cells metabolism, provides reliable
estimates of the blood volume in BC bottles, with a mean error
of 0.2mL. The error margin is higher (i.e., 1mL), for BC bottles
received from hematology wards, due to anemia or impaired red
blood cells metabolism (Chang et al., 2015). One limitation of this
device is that volume is monitored in batches and not for each
bottle individually. A device developed on the new BC system
Virtuo (bioMerieux) provides an automated volume estimation
of each bottle based on a photometric detection of liquid level,
but, as far as we know, its accuracy has not yet been evaluated in
clinical studies.
Incubation Time
Bottles are usually incubated for a maximum duration of 5–
7 days (Lamy and Seifert, 2012; Baron et al., 2013; Kirn and
Weinstein, 2013; Accoceberry et al., 2015a). Very few micro-
organisms are recovered between 5 and 7 days. Among these,
clinically significant bacteria or fungi are mostly low-level CO2
producers, or slowly growing micro-organisms (e.g., Candida
spp, strict anaerobes, or Brucella sp). Marginson et al. (2014)
found that 2.7% of all positive BC turned positive between
5 and 7 days, including 0.5% of clinically significant micro-
organism (Marginson et al., 2014). When infective endocarditis
is suspected but BC remain negative on day 5, some guidelines
state that bottles incubation must be prolonged until day 15
or more (Mainardi and Ricardo, 2012; Accoceberry et al.,
2015b). However, these recommendations are mostly based
on data originating from studies performed before the use
of automated BC systems and highly-efficient culture media
(Petti et al., 2006). Studies based on continuous-monitoring BC
systems have shown that prolonged incubation time does not
significantly improve the overall sensitivity of BC, even for IE
due to fastidious bacteria from the HACEK group (Haemophilus,
Aggregibacter, Cardiobacterium, Eikenella, Kingella) as all of
these were recovered from a standard 5-day incubation protocol
in various studies (Wilson et al., 1993; Baron et al., 2005a;
Petti et al., 2006). Prolonged cultures of specific BC bottles for
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the detection of fastidious zoonotic agents in blood culture-
negative endocarditis (BCNE) are exceptionally useful, and are
not recommended in routine practice. Fournier et al. (2010)
have demonstrated that serological analysis was the most useful
specimen providing a diagnosis of 47.7% of 745 tested patients
with suspected BCNE (mainly Q fever and Bartonella infections;
Fournier et al., 2010). According to the local epidemiology, the
diagnosis of BCNE is based on systematic serological testing
for Coxiella burnetii, Bartonella spp., Brucella spp., Aspergillus
spp., Mycoplasma pneumonia, Legionella pneumophila followed
by specific polymerase chain reaction (PCR) assays (Tropheryma
whipplei, Bartonella spp. and fungi) (Baddour et al., 2015; Habib
et al., 2015).
CONCLUSIONS
BCs are among the most common microbiological tests
performed in 2016 and remain the first and essential diagnostic
tool for detection of BSIs. Best practices of BC sampling require
thorough understanding of several issues including appropriate
ordering BCs, timing of BC collection, skin preparation, sample
site, impact of the volume sampled. Quality control programs,
including automated controls of pre-analytical variables should
be reinforced to address the deficiencies that are frequently
reported.
While both sampling strategies (i.e., multi-sampling strategy,
or single-sampling strategy) are acceptable according to the
guidelines, additional progresses are expected with the single-
sampling strategy that is probably more convenient for patients
and healthcare workers and probably associated with reduced
costs, earlier initiation of empirical anti-infective treatment when
indicated, and lower risk of occupational exposure to blood-
transmissible pathogens. Today, evidence-based clinical data to
document the yield of this strategy deserve to be improved and a
large multicenter randomized trial is required to decipher the pro
and cons of both strategies of BC collection for the diagnosis of
BSIs and infective endocarditis.
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